Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Disease area: Pulmonary vascular diseases

Abstract

Objectives:The aim of this study was to analyze prevalence and type of pulmonary manifestations in patients with primary antiphospholipid syndrome (PAPS), possible relationship to existing cardiac manifestations and their association to antiphospholipid antibody (aPL) type. This is the review of the Serbian APS registry.Methods:Our cross-sectionals study comprises of 318 patients with PAPS. aPL analysis included detection of aCL, ß₂GPI and LA and served to evaluate associations with cardiac and pulmonary manifestations. Results: In patient with pulmonary embolism and infarction, significant prevalence of myocardial infarction, unstable angina pectoris, venous thrombosis arterial thrombosis, deep venous thrombosis of low extremities and superficial thrombophlebitis of low extremities has been observed. Patients with primary pulmonary hypertension were more prone to unstable angina pectoris and patients with secondary pulmonary hypertension to venous thrombosis, and inferior extremities deep venous thrombosis. Patients with pulmonary microthrombosis were more prone to unstable angina pectoris, arterial thrombosis, venous thrombosis, inferior extremities deep venous thrombosis and inferior extremities superficial thrombophlebitis. The presence of LA was significantly higher in patients with pulmonary embolism and infarction, in secondary pulmonary hypertension and in patients with pulmonary microthrombosis.Conclusion:Presence of LA was associated with distinct pulmonary manifestations in PAPS. There is strong link between some cardiac and pulmonary manifestations in PAPS patients, suggesting complexity and evolutionary nature of PAPS.


Rating:

Share or cite this content

Citations should be made in the following way:
Milica Kontic (Belgrade, Republic of Serbia), Milica Kontic, Ljudmila Stojanovich, Aleksandra Djokovic. Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study. Eur Respir J 2015; 46: Suppl. 59, 3684

Member's Comments

No comment yet.

Related content which might interest you: Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019 Idiopathic Pulmonary Fibrosis based on disease behavior: Workshop summary of a Japanese multicenter study Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Pulmonary manifestations in patients with IgG4-related disease at a tertiary care institute Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Eur Respir J, 50 (5) 1700610; 10.1183/13993003.00610-2017 Year: 2017 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Guideline 2017 Year: 2017 Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Source: Eur Respir J 2012; 39: 945-955 Year: 2012 Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Cardiac sarcoidosis is more frequent in males – Large cohort (n=1375) sarcoid patients analysis – 5 years experience in the National TB & Lung Diseases Research Institute in Warsaw, Poland Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001 Subcutaneous sarcoidosis: A clinical analysis of nine patients Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015